895 related articles for article (PubMed ID: 22325219)
81. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
Jiao XL; Chen D; Wang JG; Zhang KJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
[TBL] [Abstract][Full Text] [Related]
82. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
83. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.
Ding MX; Lin XQ; Fu XY; Zhang N; Li JC
World J Gastroenterol; 2006 Jul; 12(28):4582-5. PubMed ID: 16874878
[TBL] [Abstract][Full Text] [Related]
84. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
85. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
Wu J; Zhang JR; Jiang XQ; Cao XG
Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
[TBL] [Abstract][Full Text] [Related]
86. [Expression and clinical significance of BRCA1 in human esophageal squamous cell carcinoma].
Yang YX; Xue LY; Dong LJ; Fu M; Zhan QM; Tong T
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):905-9. PubMed ID: 23336376
[TBL] [Abstract][Full Text] [Related]
87. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
[TBL] [Abstract][Full Text] [Related]
88. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
89. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
90. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
91. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
92. Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma.
Shiozaki A; Nakashima S; Ichikawa D; Fujiwara H; Konishi H; Komatsu S; Kubota T; Okamoto K; Iitaka D; Shimizu H; Nako Y; Takemoto K; Kishimoto M; Otsuji E
Anticancer Res; 2013 Oct; 33(10):4329-35. PubMed ID: 24123000
[TBL] [Abstract][Full Text] [Related]
93. Up-regulation of miR-765 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Jiang B; Xu G; Lv HQ; Huang M; Li Z
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3789-3794. PubMed ID: 29949154
[TBL] [Abstract][Full Text] [Related]
94. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
[TBL] [Abstract][Full Text] [Related]
95. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
96. C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M; Yamamoto H; Masuzawa T; Takahashi H; Uemura M; Haraguchi N; Nishimura J; Hata T; Yamasaki M; Miyata H; Takemasa I; Mizushima T; Takiguchi S; Doki Y; Mori M
Ann Surg Oncol; 2013 Aug; 20(8):2699-705. PubMed ID: 23435632
[TBL] [Abstract][Full Text] [Related]
97. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
Gao Y; Xuan XY; Zhang HY; Wang F; Zeng QR; Wang ZQ; Li SS
Cell Biol Int; 2012 Jun; 36(6):571-7. PubMed ID: 22360285
[TBL] [Abstract][Full Text] [Related]
98. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
99. Prognostic significance of NBS1 and Snail expression in esophageal squamous cell carcinoma.
Kuo KT; Chou TY; Hsu HS; Chen WL; Wang LS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S549-57. PubMed ID: 21881923
[TBL] [Abstract][Full Text] [Related]
100. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Minato T; Yamamoto Y; Seike J; Yoshida T; Yamai H; Takechi H; Yuasa Y; Furukita Y; Goto M; Bando Y; Tangoku A
Ann Surg Oncol; 2013 Jan; 20(1):209-17. PubMed ID: 22847125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]